Back to search

Article

Prognostic significance of the peripheral blood CD4/CD8 ratio in lung cancer patients: A meta-analysis

2026-03-11

Abstract excerpt

<title>Abstract</title> <p>Background Lung cancer is among the most prevailing and lethal malignant tumors globally, with patients generally exhibiting poor prognoses. The peripheral blood CD4/CD8 ratio serves as a commonly used indicator of immune status, yet its predictive value for treatment outcomes in lung cancer remains controversial. Method This study employed systematic review and meta-analysis methodol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1de9888-3f7d-531a-8683-12c25b2c6c76
DOI
10.21203/rs.3.rs-8518407/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic significance of the peripheral blood CD4/CD8 ratio in lung cancer patients: A meta-analysisDOI 10.21203/rs.3.rs-8518407/v1
The Relationship Between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective StudySemantic proximity
Characteristics and Hematological Indicators Predictors of Immunotherapy Response in Advanced Non-Small Cell Lung CancerSemantic proximity
Predictive value of the biomarker of peripheral blood of NSCLC patients responding to anti-PD-1 treatmentSemantic proximity
The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.Semantic proximity
A Peripheral Blood Transcriptomic Biomarker Panel Identified by Multiple Machine Learning Algorithms Enables Early Diagnosis and Prognosis Prediction in Lung CancerSemantic proximity
Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer.Semantic proximity
Blood-based Genomic and Cellular Determinants of Response to Neoadjuvant PD-1 Blockade in Patients with Non-Small-Cell Lung CancerSemantic proximity
Effect of PD-1 inhibitor combined with chemotherapy on cytokines and immune cell function in patients with advanced lung cancerSemantic proximity
Prognostic value of the ratio of Interleukin-2 and Interleukin-10 in patients with hepatocellular carcinoma treated with anti-PD-1 therapySemantic proximity
A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.Semantic proximity
A Novel Gene Expression Signature-Based on B-Cell Proportion to Predict Prognosis of Patients with Lung AdenocarcinomaSemantic proximity
The Predictive efficacy of tumor mutational burden for immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trialsSemantic proximity
Select a neighboring publication to make it the new centre.